Pharmacotherapy of mood disorders and psychosis in pre- and post-natal women

References

• Gavin NI, Gaynes BN, Lohr KN, et al. Perinatal depression: a systematic review of prevalence and incidence. Obstetrics Gynecol. 2005;106:1071–1083.
   PubMed Web of Science ®Google Scholar
• Ko JY, Farr SL, Dietz PM, et al. Depression and treatment among U.S. pregnant and nonpregnant women of reproductive age, 2005-2009. J Women’s Health. 2012;21:830–836.
   PubMed Web of Science ®Google Scholar
• Huber MT, Braun HA, Krieg JC. On the impact of episode sensitization on the course of recurrent affective disorders. J Psychiatr Res. 2001;35:49–57.
   PubMed Web of Science ®Google Scholar
• Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry. 1992;149:999–1010.
   PubMed Web of Science ®Google Scholar
• Andreescu C, Mulsant BH, Rothschild AJ, et al. Pharmacotherapy of major depression with psychotic features: what is the evidence? Psychiatr Ann. 2006;36:31–38.
   Web of Science ®Google Scholar
• Wijkstra J, Burger H, van den Broek WW, et al. Long-term response to successful acute pharmacological treatment of psychotic depression. J Affective Disord. 2010;123:238–242.
   PubMed Web of Science ®Google Scholar
• Gaudiano BA, Zimmerman M. The relationship between childhood trauma history and the psychotic subtype of major depression. Acta Psychiatrica Scandinavica. 2010;121:462–470.
   PubMed Web of Science ®Google Scholar
• Dubovsky SL. What we don’t know about psychotic depression [editorial]. Biol Psychiatry. 1991;30:533–536.
   PubMed Web of Science ®Google Scholar
• Dubovsky SL. Treatment of bipolar depression. Psychiatr Clin North Am. 2005;28:349–370.
   PubMed Web of Science ®Google Scholar
• Alvir JM, Woerner MG, Gunduz H, et al. Obstetric complications predict treatment response in first-episode schizophrenia. Psychol Med. 1999;29:621–627.
   PubMed Web of Science ®Google Scholar
• Hasan A, Falkai P, Wobrock T, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia. Part 3: update 2015 management of special circumstances: depression, suicidality, substance use disorders and pregnancy and lactation. World J Biol Psychiatry. 2015;16:142–170.
   PubMed Web of Science ®Google Scholar
• Taylor CL, Stewart R, Ogden J, et al. The characteristics and health needs of pregnant women with schizophrenia compared with bipolar disorder and affective psychoses. BMC Psychiatry. 2015;15:88.
   PubMed Web of Science ®Google Scholar
• Cantwell R, Clutton-Brock T, Cooper G, et al. Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The eighth report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG: an International Journal of Obstetrics & Gynecology. 2011;118:1–203.
   Web of Science ®Google Scholar
• Fur DC, Calvert C, Ronsmans C, et al. Contribution of suicide and injuries to pregnancy-related mortality in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Psychiatry. 2014;1:213–225.
   PubMed Web of Science ®Google Scholar
• Ban L, Tata LJ, West J, et al. Live and non-live pregnancy outcomes among women with depression and anxiety: a population-based study. PLoS One. 2012;7:e43462.
   PubMed Web of Science ®Google Scholar
• Malm H, Sourander A, Gissler M, et al. Pregnancy complications following prenatal exposure to SSRIs or maternal psychiatric disorders: results from population-based national register data. Am J Psychiatry. 2015;172:1224–1232.
   PubMed Web of Science ®Google Scholar
• Grote NK, Bridge JA, Gavin AR, et al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry. 2010;67:1012–1024.
   PubMed Web of Science ®Google Scholar
• El Marroun H, Jaddoe VWV, Hudziak JJ, et al. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psychiatry. 2012;69:706–714.
   PubMed Web of Science ®Google Scholar
• Howard LM, Kirkwood G, Latinovic R. Sudden infant death syndrome and maternal depression. J Clin Psychiatry. 2007;68:1279–1283.
   PubMed Web of Science ®Google Scholar
• Stein A, Rm P, Sh G, et al. Effects of perinatal mental disorders on the fetus and child. Lancet. 2014;384(9956):1800–1819.
   PubMed Web of Science ®Google Scholar
• Skurtveit S, Selmer R, Roth C, et al. Prenatal exposure to antidepressants and language competence at age three: results from a large population-based pregnancy cohort in Norway. BJOG: an International Journal of Obstetrics & Gynecology. 2014;121:1621–1631.
   Web of Science ®Google Scholar
• Deave T, Heron J, Evans J, et al. The impact of maternal depression in pregnancy on early child development. BJOG: an International Journal of Obstetrics & Gynecology. 2008;115:1043-`051.
   Web of Science ®Google Scholar
• Pearson RM, Evans J, Kounali D, et al. Maternal depression during pregnancy and the postnatal period: risks and possible mechanisms for offspring depression at age 18 years. JAMA Psychiatry. 2013;70:1312–1319.
   PubMed Web of Science ®Google Scholar
• Rifkin-Graboi A, Bai J, Chen HI, et al. Prenatal maternal depression associates with microstructure of right amygdala in neonates at birth. Biol Psychiatry. 2013;74:837–844.
   PubMed Web of Science ®Google Scholar
• Lebel C, Walton M, Letourneau N, et al. Prepartum and postpartum maternal depressive symptoms are related to children’s brain structure in preschool. Biol Psychiatry. 2016;80:859–868.
   PubMed Web of Science ®Google Scholar
• Zhang H, Su Q, Yao D, et al. Prolactin, a potential mediator of reduced social interactive behavior in newborn infants following maternal depressive symptoms. J Affective Disord. 2017;215:274–280.
   PubMed Web of Science ®Google Scholar
• Fernandes M, Stein A, Srinivasan K, et al. Foetal exposure to maternal depression predicts cortisol responses in infants: findings from rural South India. Child Care, Health Development. 2015;41:677–686.
   PubMed Web of Science ®Google Scholar
• Davis EP, Glynn LM, Waffam F, et al. Prenatal maternal stress programs infant stress regulation. J Child Psychol Psychiatry Allied Disciplines. 2011;52:119–129.
   PubMed Web of Science ®Google Scholar
• Smith AK, Newport DJ, Ashe MP, et al. Predictors of neonatal hypothalamic-pituitary axis activity at delivery. Clin Endocrinol. 2011;75:90–95.
   PubMed Web of Science ®Google Scholar
• Pawluski JL, Brain UM, Underhill CM, et al. Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function. Psychoneuroendocrinology. 2012;37:1019–1028.
   PubMed Web of Science ®Google Scholar
• Brennan PA, Pargas R, Walker EF, et al. Maternal depression and infant cortisol: influences of timing, comorbidity and treatment. J Child Psychol Psychiatry Allied Disciplines. 2008;49:1099–1107.
   PubMed Web of Science ®Google Scholar
• Matevosyan NR. Pregnancy and postpartum specifics in women with schizophrenia: a meta-study. Arch Gynecol Obstet. 2011;283:141–147.
   PubMed Web of Science ®Google Scholar
• Hizkiyahu R, Levy A, Sheiner E. Pregnancy outcome of patients with schizophrenia. Am J Perinatol. 2010;27:19–24.
   PubMed Web of Science ®Google Scholar
• Gentile S. Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bull. 2010;36:518–544.
   PubMed Web of Science ®Google Scholar
• van Mullem C, Tillett J. Psychiatric disorders in pregnancy. J Perinat Neunat Nurs. 2009;23:124–130.
   PubMed Web of Science ®Google Scholar
• Habermann F, Fritzsche J, Fuhlbruck F, et al. Atypical antipsychotic drugs and pregnancy outcome. A prospective, cohort study. J Clin Psychopharmacol. 2013;33:453–462.
   PubMed Web of Science ®Google Scholar
• Deligiannidis KM, Byatt N, Freeman MP. Pharmacotherapy for mood disorders in pregnancy. A review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring. J Clin Psychopharmacol. 2014;34:244–255.
   PubMed Web of Science ®Google Scholar
• Newport DJ, Calamaras MR, DeVane CL, et al. Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry. 2007;164:1214–1220.
   PubMed Web of Science ®Google Scholar
• Galbally M, Snellen M, Lewis AJ. A review of the use of psychotropic medication in pregnancy. Curr Opin Obstetrics Gynecol. 2011;23:408–414.
   PubMed Web of Science ®Google Scholar
• Yonkers KA, Wisner KL, Stewart DE, et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry. 2009;31:403–413.
   PubMed Web of Science ®Google Scholar
• Huybrechts KF, Palmsten K, Mogun H, et al. National trends in antidepressant medication treatment among publicly insured pregnant women. Gen Hosp Psychiatry. 2013;35:265–271.
   PubMed Web of Science ®Google Scholar
• Heininen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littelton, MA: Publishing Sciences Group; 1977.
   Google Scholar
• Louik A, Lin AE, Werler MM, et al. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med. 2007;356:2675–2683.
   PubMed Web of Science ®Google Scholar
• Berard A, Iessa N, Chaabane S, et al. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016;81:589–604.
   PubMed Web of Science ®Google Scholar
• Nakhai-Pour HR, Broy P, Berard A. Use of antidepressants during pregnancy and the risk of spontaneous abortion. CMAJ. 2010;182:1031–1037.
   PubMed Web of Science ®Google Scholar
• Noorlander CW, Ververs FFT, Nikkels PGJ, et al. Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities. PLoS One. 2008;e2782.
   PubMed Web of Science ®Google Scholar
• Hemels ME, Einarson A, Koren G, et al. Antidepressant use during pregnancy and the rates of spontaneous abortion: a meta-analysis. Ann Pharmacother. 2005;39:803–809.
   PubMed Web of Science ®Google Scholar
• Andersen JT, Anderson NL, Horwitz H, et al. Exposure to selective serotonin reuptake inhibitors in early pregnancy and the risk of miscarriage. Obstetrics Gynecol. 2014;124:655–661.
   PubMed Web of Science ®Google Scholar
• Berard A, Zhao JP, Sheehy O. Sertraline use during pregnancy and the risk of major malformations. Am J Obset Gynecol. 2015;212:795e1–e12.
   Web of Science ®Google Scholar
• Malm H, Artama M, Gissler M, et al. Selective serotonin reuptake inhibitors and risk for major congenital anomalies. Obstetrics Gynecol. 2011;118:111–120.
   PubMed Web of Science ®Google Scholar
• Alwan S, Bandoli G, Chambers CD. Maternal use of selective serotonin-reuptake inhibitor and risk of persistent pulmonary hypertension of the newborn. Clin Pharmacol Ther. 2016;100:34–41.
   PubMed Web of Science ®Google Scholar
• Grigoriadis S, Vonderporten EH, Mamisashvili L, et al. Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis. BMJ. 2014;348:f6932.
   PubMed Web of Science ®Google Scholar
• Huybrechts KF, Bateman BT, Palmsten K, et al. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension in the newborn. JAMA. 2015;313:2142–2151.
   PubMed Web of Science ®Google Scholar
• Gentile S, Galbally M. Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: a systematic review. J Affective Disord. 2011;128:1–9.
   PubMed Web of Science ®Google Scholar
• Croen LA, Grether JK, Yoshida CK, et al. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry. 2011;68:1104–1112.
   PubMed Web of Science ®Google Scholar
• Boukhris T, Sheehy O, Mottron L, et al. Antidepressant use during pregnancy and the risk of autism spectrum disorder in children. JAMA Pediatr. 2016;170:117–124.
   PubMed Web of Science ®Google Scholar
• Rai D, Lee BK, Dalman C, et al. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ. 2013;346:f2059.
   PubMed Web of Science ®Google Scholar
• Hviid A, Melbye M, Pasternak B. Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. N Engl J Med. 2013;169:2406–2415.
   Web of Science ®Google Scholar
• Sorensen MJ, Gronborg TK, Christensen J, et al. Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clin Epidemiol. 2013;5:449–459.
   PubMedGoogle Scholar
• Sujan AC, Rickert ME, Oberg AS, et al. Assocations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit/hyperactivity disorder in offspring. JAMA. 2017;317:1553–1562.
   PubMed Web of Science ®Google Scholar
• Brown HK, Ray JG, Wilton AS, et al. Association between serotonergic antidepressant use during pregnancy and autism spectrum disorder in children. JAMA. 2017;317:1544–1552.
   PubMed Web of Science ®Google Scholar
• Viktorin A, Uher R, Kolevzon A, et al. Association of antidepressant medication use during pregnancy with intellectual disability in offspring. JAMA Psychiatry. 2017. DOI:10.1001/jamapsychiatry.2017.1727.
   PubMed Web of Science ®Google Scholar
• Palmsten K, Hernandez-Diaz S, Huybrechts KF, et al. Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. BMJ. 2013;347:f4877.
   PubMed Web of Science ®Google Scholar
• Grzeskowiak LE, McBain R, Dekker GA, et al. Antidepressant use in late gestation and risk of postpartum hemorrhage: a retrospective cohort study. BJOG: an International Journal of Obstetrics & Gynecology. 2016;123:1929–1936.
   Web of Science ®Google Scholar
• Lupattelli A, Spigset O, Koren G, et al. Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol. 2014;34:143–148.
   PubMed Web of Science ®Google Scholar
• Gentile S. On categorizing gestational, birth, and neonatal complications following late exposure to antidepressants: the prenatal antidepressant exposure syndrome. CNS Spectr. 2010;15:167–185.
   PubMed Web of Science ®Google Scholar
• Kalfoglou AL. Ethical and clinical dilemmas in using psychotropic medications during pregnancy. AMA J Ethics. 2016;18:614–623.
   PubMedGoogle Scholar
• Pinheiro E, Bogen DL, Hoxha D, et al. Sertraline and breastfeeding: review and meta-analysis. Arch of Womens Ment Health. 2015;18:139–146.
   PubMed Web of Science ®Google Scholar
• Davanzo R, Copertino M, De Cunto A, et al. Antidepressant drugs and breastfeeding: a review of the literature. Breastfeed Med: Off J Acad Breastfeed Med. 2011;6:89–98.
   PubMed Web of Science ®Google Scholar
• Orsolini L, Bellantuono C. Serotonin reuptake inhibitors and breastfeeeding: a systematic review. Hum Psychopharmacol. 2015;30:4–20.
   PubMed Web of Science ®Google Scholar
• Weissman AM, Levy BT, Hartz AJ, et al. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry. 2004;161:1066–1078.
   PubMed Web of Science ®Google Scholar
• Gentile S. Use of contemporary antidepressants during breast feeding: a proposal for specific drug safety index. Drug Saf. 2007;30:107–121.
   PubMed Web of Science ®Google Scholar
• Lanza Di Scalea T, Wisner KL. Antidepressant medication use during breastfeeding. Clin Obstet Gynecol. 2009;52:483–497.
   PubMed Web of Science ®Google Scholar
• Morris R, Matthes J. Serotonin syndrome in a breast-fed neonate. BMJ Case Rep. 2015;2015:bcr2015209418. DOI:10.1136/bcr-2015-209418.
   Google Scholar
• Huybrechts KH, Palmsten K, Avorn J, et al. Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med. 2014;370:2397–2407.
   PubMed Web of Science ®Google Scholar
• Ban L, Gibson JE, West J, et al. Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study. BJOG: an International Journal of Obstetrics & Gynecology. 2014;121:1471–1481.
   Web of Science ®Google Scholar
• Gentile S. Tricyclic antidepressants in pregnancy and puerperium. Expert Opin Drug Saf. 2014;13:207–225.
   PubMed Web of Science ®Google Scholar
• Reis M, Kallen B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med. 2010;40:1723–1733.
   PubMed Web of Science ®Google Scholar
• Nulman I, Rovet J, Stewart DE, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med. 1997;336:258–262.
   PubMed Web of Science ®Google Scholar
• Nulman I, Rovet J, Stewart DE, et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry. 2002;159:1889–1895.
   PubMed Web of Science ®Google Scholar
• Ter Horst PG, van der Linde S, Smith JP, et al. Clomipramine concentration and withdrawal symptoms in 10 neonates. Br J Clin Pharmacol. 2012;73:295–302.
   PubMed Web of Science ®Google Scholar
• Einarson A, Fatoye B, Sarkar M, et al. Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. Am J Psychiatry. 2001;158:1728–1730.
   PubMed Web of Science ®Google Scholar
• Hudson JL, Wohlreich MM, Kajdasz DK, et al. Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials.;. Hum Psychopharmacol. 2005;20:327–341.
   PubMed Web of Science ®Google Scholar
• Ramos E, St-Andre M, Berard A. Association between antidepressant use during pregnancy and infants born small for gestational age. Can J Psychiatry. 2010;55:643–652.
   PubMed Web of Science ®Google Scholar
• Palmsten K, Huybrechts KF, Michels KB, et al. Antidepressant use and risk for preeclampsia. Epidemiology. 2013;24:682–691.
   PubMed Web of Science ®Google Scholar
• Lennestal R, Kallen B. Delivery outcome in relation to maternal use of some recently introduced antidepressants. J Clin Psychopharmacol. 2007;27:607–613.
   PubMed Web of Science ®Google Scholar
• Chun-Fai-Chan B, Koren G, Fayez I, et al. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obset Gynecol. 2005;192:932–936.
   PubMed Web of Science ®Google Scholar
• Djulus J, Koren G, Einarson TR, et al. Exposure to mirtazepine during pregnancy: a prospective, comparative study of birth outcomes. J Clin Psychiatry. 2006;67:1280–1284.
   PubMed Web of Science ®Google Scholar
• Alwan S, Reefhuis J, Botto LD, et al. Maternal use of bupropion and risk for congenital heart defects. Am J Obset Gynecol. 2010;203:e1–e6.
   PubMed Web of Science ®Google Scholar
• Figueroa R. Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring. J Dev Behav Pediatrics. 2010;31:641–648.
   PubMed Web of Science ®Google Scholar
• Newport DJ, Ritchie JC, Knight BT, et al. Venlafaxine in human breast milk and nursing infant plasma: determination of exposure. J Clin Psychiatry. 2009;70:1304–1310.
   PubMed Web of Science ®Google Scholar
• Jones I, Chandra PS, Dazzan P, et al. Bipolar disorder, affective psyshosis, and schizophrenia in pregnancy and the post-partum period. Lancet. 2014;384:1789–1799.
   PubMed Web of Science ®Google Scholar
• Anderson EL, Reti IM. ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosom Med. 2009;71:235–242.
   PubMed Web of Science ®Google Scholar
• Bulut M, Bez Y, Kaya MC, et al. Electroconvulsive therapy for mood disorders in pregnancy. J Ect. 2013;29:e19–e20.
   PubMed Web of Science ®Google Scholar
• Bulbul F, Us C, Alpak G, et al. Electroconvulsive therapy in pregnant patients. Gen Hosp Psychiatry. 2013;35:636–639.
   PubMed Web of Science ®Google Scholar
• Halmo M, Spodniakova B, Nosal’ova P. Fetal spasms after the administration of electroconvulsive therapy in pregnancy: our experience. J ECT. 2014;30:e24–e6.
   PubMed Web of Science ®Google Scholar
• Calaway K, Coshal S, Jones K, et al. A systematic review of the safety of electroconvulsive use during the first trimester of pregnancy. J ECT. 2016;32:230–235.
   PubMed Web of Science ®Google Scholar
• Wald MF, Muzyk AJ, Clark D. Bipolar depression. Psychiatr Clin America. 2016;39:57–74.
   PubMed Web of Science ®Google Scholar
• Viguera AC, Tondo L, Koukopoulos AE, et al. Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatry. 2011;168:1179–1185.
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L, Faedda GL, et al. Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders. J Clin Psychiatry. 1996;57:441–448.
   PubMed Web of Science ®Google Scholar
• Viguera AC, Nonacs R, Cohen LS, et al. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry. 2000;157:179–184.
   PubMed Web of Science ®Google Scholar
• Goodwin FK, Jamison KR. Manic depressive illness. New York: Oxford University Press; 1991.
   Google Scholar
• di Florio A, Forty L, Gordon-Smith K, et al. Perinatal episodes across the mood disorder spectrum. JAMA Psychiatry. 2013;70:168–175.
   PubMed Web of Science ®Google Scholar
• Dubovsky SL, Dubovsky AN. Concise guide to mood disorders. Washington (DC): American Psychiatric Press; 2002.
   Google Scholar
• Bergink V, Bouvy PF, Vervoort JS, et al. Prevention of postpartum psychosis and mania in women at high risk. Am J Psychiatry. 2012;169:609–615.
   PubMed Web of Science ®Google Scholar
• Bauer M, Mitchner L. What is a “mood stabilizer”? An evidence-based response. Am J Psychiatry. 2004;161:3–18.
   PubMed Web of Science ®Google Scholar
• Pinelli JM, Symington AJ, Cunningham KA, et al. Case report and review of the perinatal implications of maternal lithium use. Am J Obset Gynecol 2002;187:245–249.
   Google Scholar
• Gentile S. Drug treatment for mood disorders in pregnancy. Curr Opin Psychiatry. 2011;24:34–40.
   PubMed Web of Science ®Google Scholar
• McKinght RF, Adida M, Budge K, et al. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012;379:721–728.
   PubMed Web of Science ®Google Scholar
• Patorno E, Huybrechts KF, Bateman BT, et al. Lithium use in pregnancy and the risk of cardiac malformations. N Engl J Med. 2017;376:2245–2254.
   PubMed Web of Science ®Google Scholar
• Iqbal MM, Gundlapalli SP, Ryan WG, et al. Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants. South Med J. 2001;94:304–322.
   PubMed Web of Science ®Google Scholar
• Chaudron L, Jefferson JW. Mood stabilizers during breastfeeding: a review. J Clin Psychiatry. 2000;61:79–90.
   PubMed Web of Science ®Google Scholar
• Koren G, Moretti M, Ito S. Continuing drug therapy while breastfeeding. Part 2. Common misconceptions of physicians. Can Fam Physician. 1999;45:1173–1175.
   PubMed Web of Science ®Google Scholar
• Vaida FJ, Dodd S, Horgan D. Lamotrigine in epilepsy, pregnancy and psychiatry – a drug for all seasons? J Clin Neurosci. 2013;20:13–16.
   PubMed Web of Science ®Google Scholar
• van Ness PC. Breastfeeding in women with epilepsy. JAMA Neurol. 2013;70:1357–1358.
   PubMed Web of Science ®Google Scholar
• Pearlstein T. Use of psychotropic medication during pregnancy and the postpartum period. Women’s Health. 2013;9:605–615.
   PubMedGoogle Scholar
• Bromley RL, Mawer G, Clayton-Smith J, et al. Autism spectrum disorders following in utero exposure to antiepileptic drugs (ltr to ed). Neurology. 2008;71:1923–1924.
   PubMed Web of Science ®Google Scholar
• Cohen MJ, Meador KJ, Browning N, et al. Fetal antiepileptic drug exposure: adaptive and emotional/behavioral functioning at age 6 years. Epilepsy Behav. 2013;29:308–315.
   PubMed Web of Science ®Google Scholar
• Meador KJ, Baker GA, Browning N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009;360:1597–1605.
   PubMed Web of Science ®Google Scholar
• Veiby G, Engelsen BA, Gilhus NE. Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding. A prospective cohort study on children of women with epilepsy. JAMA Neurol. 2013;70:1367–1374.
   PubMed Web of Science ®Google Scholar
• Meador KJ, Baker GA, Browning N, et al. Breastfeeding in children of women taking antiepileptic drugs. Cognitive outcomes at age 6 years. JAMA Pediatr. 2014;168:729–736.
   PubMed Web of Science ®Google Scholar
• Newton ER, Hale TW. Drugs in breast milk. Clin Obstet Gynecol. 2015;58:868–884.
   PubMed Web of Science ®Google Scholar
• Robinson GE. Treatment of schizophrenia in pregnancy and postpartum. J Popul Ther Clin Pharmacol. 2012;19:e380–e6.
   PubMedGoogle Scholar
• Reis M, Kallen B. Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol. 2008;28:279–288.
   PubMed Web of Science ®Google Scholar
• Lin HC, Chen I-J, Chen Y-H, et al. Maternal schizophrenia and pregnancy outcome: does use of antipsychotics make a difference? Schizophrenia Res. 2010;116:55–60.
   PubMed Web of Science ®Google Scholar
• Wisner KL, Jeong H, Chambers C. Use of antipsychotics during pregnancy. Pregnant women get sick-sick women get pregnant. JAMA Psychiatry. 2016;73:901–903.
   PubMed Web of Science ®Google Scholar
• Crawford MB, DeLisi LE. Issues related to sex differences in antipsychotic treatment. Curr Opin Psychiatry. 2016;29:211–217.
   PubMed Web of Science ®Google Scholar
• Huybrechts KF, Hernandez-Diaz S, Patorno E, et al. Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiatry. 2016;73:938–946.
   PubMed Web of Science ®Google Scholar
• Kulkarni J, Storch A, Baraniuk A, et al. Antipsychotic use in pregnancy. Expert Opin Pharmacother. 2015;16:1335–1345.
   PubMed Web of Science ®Google Scholar
• Frank E, Kupfer DJ, Ehlers CL, et al. Interpersonal and social rhythm therapy for bipolar disorder: integrating interpersonal and behavioral approaches. Behav Therapist. 1994;17:143–149.
   Google Scholar
• Grunhaus L, Schreiber S, Dolberg O, et al. Response to ECT in major depression: are there differences between unipolar and bipolar depression? Bipolar Disord. 2002;4(suppl 1):91–93.
   PubMed Web of Science ®Google Scholar
• Tiihonen J, Mittendorfer-Rutz E, Majaak M, et al. Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29,823 patients with schizophrenia. JAMA Psychiatry. 2017;74(7):686–693.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Bassett D, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry. 2015;49:1087–1206.
   PubMed Web of Science ®Google Scholar
• Meltzer-Brody S, Jones I. Optimizing the treatment of mood diosrders in the perinatal period. Dialogues Clin Neurosci. 2015;17:207–218.
   PubMed Web of Science ®Google Scholar
• Lam RW, Levitt AJ, Levitan RD, et al. Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder. A randomized clinical trial. JAMA Psychiatry. 2016;73:56–63.
   PubMed Web of Science ®Google Scholar
• Keshtkar M, Ghanizadeh A, Firoozabadi A. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for the treatment of major depressive disorder, a randomized controlled clinical trial. J ECT. 2011;27:310–314.
   PubMed Web of Science ®Google Scholar
• Miklowitz DJ, Otto MW, Frank E, et al. Psychosocial treatments for bipolar depression. A 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry. 2007;64:419–427.
   PubMed Web of Science ®Google Scholar
• Dubovsky SL. Clinical guide to psychotropic medications. New York: WW Norton; 2005.
   Google Scholar
• Kendler KS. Psychosis within vs outside of major mood episodes. A key prognostic and diagnostic criterion. JAMA Psychiatry. 2013;70:1263–1264.
   PubMed Web of Science ®Google Scholar
• Leadholm A, Rothschild AJ, Nolen WA, et al. The treatment of psychotic depression: is there consensus among guidelines and psychiatrists? J Affective Disord. 2013;145:214–220.
   PubMed Web of Science ®Google Scholar
• Goodnick PJ. Verapamil prophylaxis in pregnant women with bipolar disorder. Am J Psychiatry. 1993;150:1560.
   PubMed Web of Science ®Google Scholar
• Yingling DR, Utter G, Vengalil S, et al. Calcium channel blocker, nimodipine, for the treatment of bipolar disorder during pregnancy. Am J Obstet Gynecol. 2002;187:1711–1712.
   PubMed Web of Science ®Google Scholar
• Anderson PO, Sauberan JB. Modeling drug passage into human milk. Clin Pharmacol Ther. 2016;100:42–52.
   PubMed Web of Science ®Google Scholar
• Ontario HQ. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis of randomized controlled trials. Ont Health Technol Assess Ser. 2016;16:1–66.
   Google Scholar
• Dubovsky SL, Franks RD, Allen S, et al. Calcium antagonists in mania: a double-blind study of verapamil. Psychiatry Res. 1986;18:309–320.
   PubMed Web of Science ®Google Scholar
• Garza-Trevino ES, Overall JE, Hollister LE. Verapamil versus lithium in acute mania. Am J Psychiatry. 1992;149:121–122.
   PubMed Web of Science ®Google Scholar
• Gitlin MJ, Weiss JC. Verapamil as maintenance treatment in bipolar illness: a case report. J Clin Psychopharmacol. 1984;4:341–343.
   PubMed Web of Science ®Google Scholar
• Pazzaglia P, Post RM, Ketter TA, et al. Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness. J Clin Psychopharmacol. 1998;18:404–413.
   PubMed Web of Science ®Google Scholar
• Pazzaglia PJ, Post RM, Ketter TA, et al. Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation. Psychiatry Res. 1993;49:257–272.
   PubMed Web of Science ®Google Scholar
• Byerly WG, Hartmann A, Foster DE, et al. Verapamil in the treatment of maternal paroxysmal supraventricular tachycardia. Ann Emerg Med. 1991;20:552–554.
   PubMed Web of Science ®Google Scholar